ข้ามไปยังเนื้อหา

Cardiothoracic and Vascular Surgery (Pediatrics)

Economic Outcomes

Safety and effects of two red blood cell transfusion strategies in pediatric cardiac surgery patients: a randomized controlled trial. (เปิดหน้าต่างใหม่)

de Gast-Bakker DH, de Wilde RB, Hazekamp MG, Sojak V, Zwaginga JJ, Wolterbeek R, de Jonge E, Gesink-van der Veer BJ.

Source‎: Intensive Care Med 2013;39(11):2011-9.

Indexed‎: PubMed 23995984

DOI‎: 10.1007/s00134-013-3085-7

https://www.ncbi.nlm.nih.gov/pubmed/23995984 (เปิดหน้าต่างใหม่)

Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (เปิดหน้าต่างใหม่)

Miller BE, Tosone SR, Tam VK, Kanter KR, Guzzetta NA, Bailey JM, Levy JH.

Source‎: Ann Thorac Surg 1998;66(2):535-40; discussion 541.

Indexed‎: PubMed 9725399

https://www.ncbi.nlm.nih.gov/pubmed/9725399 (เปิดหน้าต่างใหม่)

Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (เปิดหน้าต่างใหม่)

Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP.

Source‎: J Thorac Cardiovasc Surg 2012;143(3):550-7.

Indexed‎: PubMed 22264414

DOI‎: 10.1016/j.jtcvs.2011.06.048

https://www.ncbi.nlm.nih.gov/pubmed/22264414 (เปิดหน้าต่างใหม่)